|Posts on Regator:||4429|
|Posts / Week:||67.8|
|Archived Since:||August 20, 2016|
(Reuters Health) - Policymakers and insurers have been pushing people addicted to opioids into abstinence-based detox programs, but a new study concludes that methadone and similar drug-maintenance treatments save lives and money.
BOSTON (Reuters) - A U.S. judge on Monday rejected a plea deal that was part of Aegerion Pharmaceuticals Inc's recent agreement to pay $40.1 million to resolve U.S. probes into its marketing of a cholesterol drug, saying it was "not in the public interest."
BRUSSELS (Reuters) - Amsterdam and Paris won the right to host two EU agencies that must leave London because of Brexit after an extraordinary ministerial meeting in Brussels that left both results decided by drawing lots from a fishbowl.
(Reuters Health) - Even though high schools in most U.S. states are required to offer training in cardiopulmonary resuscitation (CPR) to students, many do not, a new study suggests.
(Reuters Health) - Babies begin to learn words and what they mean well before they begin talking, and researchers are beginning to understand how they do it.
(Reuters Health) - Cancer patients may often experience post-traumatic stress disorder (PTSD) in the months after their tumors are diagnosed, and mental health issues can sometimes linger for years, a Malaysian study suggests.
CHICAGO (Reuters) - The U.S. Justice Department withdrew a Medicare fraud lawsuit against HCR ManorCare, removing a cloud over one the largest U.S. nursing home chains as it nears a deadline to settle a legal dispute with its landlo...
(Reuters) - A federal agency on Friday rolled out deep cuts to reimbursement rates for some lab tests under Medicare, a move that could save the government as much as $3 billion over five years, but hurt margins of U.S. laboratory companies.
BRUSSELS (Reuters) - Amsterdam won the right to host the EU's drug agency when it leaves London after Brexit after tying with Milan in a vote on Monday that was then decided by the drawing of lots, diplomatic sources said.
BRUSSELS (Reuters) - Milan and Amsterdam will run off later on Monday for the right to host the European Medicines Agency (EMA) when the EU drugs body must leave London after Brexit, diplomats said after a vote.
BRUSSELS (Reuters) - Milan came out in the lead after the first round of a European Union vote on Monday to pick the new host for the London-based European Medicines Agency (EMA) after Brexit, diplomatic sources said.
ZURICH (Reuters) - Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker is counting on to offset shrinking revenue from older medicines.
(Reuters Health) - Shaming kids about their weight doesn’t encourage them to shed excess pounds, U.S. doctors warn.
(Reuters) - Acorda Therapeutics Inc said on Monday it would stop developing its Parkinson's disease drug, less than a week after the company reported deaths in key studies testing the treatment.
(Reuters) - Acorda Therapeutics Inc said on Monday it would terminate developing its drug to treat Parkinson's disease, a week after the drugmaker reported five deaths in key studies testing the treatment.
ZURICH (Reuters) - Roche announced two trial wins for its cancer and hemophilia drugs on Monday, boosting its shares and weighing on the stocks of its main rivals.
ZURICH (Reuters) - Roche announced a double dose of trial wins on Monday, saying its immunotherapy Tecentriq mixed with other drugs made advances against lung cancer, while data suggested its haemophilia agent Hemlibra could be used by more patients.
CAPE TOWN (Reuters) - Developing new front-line antiretroviral (ARV) drugs and using technology for early diagnosis are among key steps needed to sustain momentum in fighting HIV/Aids and ending the disease as a public health threat by 2030, UNAIDS said in a report on Monday.
ZURICH (Reuters) - A late-stage trial of Roche's immuno-oncology medicine Tecentriq with other cancer drugs as an initial therapy for lung cancer met its goal of significantly reducing the risk of disease worsening or death, the Swiss drugmaker said on Monday.
SEOUL (Reuters) - South Korea on Sunday said it had confirmed an outbreak of highly pathogenic H5N6 bird flu at a duck farm in the south west of the country and raised its bird flu alert level to the highest ranking.